Cullen L M, Anderson G J, Ramm G A, Jazwinska E C, Powell L W
Clinical Sciences Unit, Queensland Institute of Medical Research, Brisbane, Australia.
Annu Rev Med. 1999;50:87-98. doi: 10.1146/annurev.med.50.1.87.
Hereditary hemochromatosis (HHC) is a common autosomal recessive disorder of iron metabolism that results in progressive iron overload and can be fatal if untreated. The hemochromatosis gene (HFE) was identified by positional cloning in 1996. Two missense mutations have been described in HFE. The majority of HHC patients are homozygous for a cysteine-to-tyrosine substitution (C282Y); however, a small number are homozygous for a histidine-to-aspartic-acid substitution (H63D) or are heterozygous for both of these mutations. Mechanisms by which C282Y and H63D may disrupt the normal functioning of HFE have been suggested, but the role of HFE in the process of normal iron metabolism has yet to be clearly defined.
遗传性血色素沉着症(HHC)是一种常见的常染色体隐性铁代谢紊乱疾病,可导致进行性铁过载,若不治疗可能致命。血色素沉着症基因(HFE)于1996年通过定位克隆被识别。HFE中已描述了两种错义突变。大多数HHC患者是半胱氨酸到酪氨酸替代(C282Y)的纯合子;然而,少数患者是组氨酸到天冬氨酸替代(H63D)的纯合子,或这两种突变的杂合子。已有人提出C282Y和H63D可能破坏HFE正常功能的机制,但HFE在正常铁代谢过程中的作用尚未明确界定。